Fort Washington Investment Advisors Inc. OH cut its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 14.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 213,330 shares of the company's stock after selling 34,670 shares during the period. Fort Washington Investment Advisors Inc. OH owned approximately 0.11% of Doximity worth $12,380,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in the company. Barclays PLC lifted its holdings in shares of Doximity by 60.5% in the 3rd quarter. Barclays PLC now owns 53,401 shares of the company's stock valued at $2,327,000 after acquiring an additional 20,125 shares during the last quarter. Stratos Wealth Partners LTD. purchased a new position in shares of Doximity in the 4th quarter worth approximately $203,000. Choreo LLC bought a new position in shares of Doximity during the 4th quarter valued at approximately $256,000. State of Alaska Department of Revenue raised its holdings in Doximity by 2.6% during the 4th quarter. State of Alaska Department of Revenue now owns 14,610 shares of the company's stock valued at $780,000 after buying an additional 370 shares during the period. Finally, Empowered Funds LLC bought a new stake in Doximity in the fourth quarter worth $3,009,000. Hedge funds and other institutional investors own 87.19% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on DOCS shares. William Blair reiterated an "outperform" rating on shares of Doximity in a research report on Friday, May 16th. Canaccord Genuity Group reduced their price objective on shares of Doximity from $71.00 to $50.00 and set a "hold" rating on the stock in a research report on Friday, May 16th. Needham & Company LLC dropped their target price on Doximity from $82.00 to $67.00 and set a "buy" rating for the company in a research report on Friday, May 16th. BTIG Research upgraded Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price target on the stock in a report on Monday, June 2nd. Finally, The Goldman Sachs Group set a $50.00 price objective on Doximity and gave the company a "neutral" rating in a report on Wednesday, May 21st. Eleven equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Doximity has an average rating of "Moderate Buy" and a consensus target price of $62.84.
Check Out Our Latest Analysis on Doximity
Doximity Stock Performance
NASDAQ:DOCS traded down $1.04 during trading hours on Friday, reaching $55.92. The company's stock had a trading volume of 1,284,854 shares, compared to its average volume of 2,136,908. The stock has a 50 day moving average price of $55.02 and a two-hundred day moving average price of $58.41. The company has a market capitalization of $10.50 billion, a P/E ratio of 55.92, a price-to-earnings-growth ratio of 4.10 and a beta of 1.32. Doximity, Inc. has a 12 month low of $25.00 and a 12 month high of $85.21.
Doximity (NASDAQ:DOCS - Get Free Report) last issued its quarterly earnings data on Thursday, May 15th. The company reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. During the same quarter in the previous year, the company posted $0.25 earnings per share. The firm's revenue for the quarter was up 17.1% on a year-over-year basis. As a group, analysts predict that Doximity, Inc. will post 0.99 EPS for the current fiscal year.
Insider Activity
In other news, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the sale, the director now owns 16,618 shares in the company, valued at approximately $946,062.74. This represents a 10.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Anna Bryson sold 45,000 shares of the business's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the transaction, the chief financial officer now owns 357,165 shares in the company, valued at approximately $20,440,552.95. This trade represents a 11.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 51,000 shares of company stock worth $2,900,770. Corporate insiders own 37.40% of the company's stock.
About Doximity
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
See Also

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.